Anna Członkowska
Anna Członkowska is an expert in Neurology at Institute of Psychiatry and Neurology (Poland). As of October 2026, ScienceLeadR ranks Anna Członkowska in the top 1% of experts worldwide for Hepatolenticular Degeneration, Brain Ischemia and Basal Ganglia Diseases. Anna Członkowska has authored 724 publications, the most recent in 2026, and is an investigator in 22 clinical trials. SLR score: 2,288 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Hepatology - Cardiology - Neurosurgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1969 - 2026
Number : 724
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Non-contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: An Analysis from ANNEXa-I Trial. PMID 42708556 — cerebral hemorrhage, hemorrhage, hematoma, antithrombin iii, factor xa inhibitors, factor xa | Ann Neurol | 2026 | 0 |
| Prevalence of Wilson's disease in Poland. PMID 42640195 — pensions, sick leave, prescriptions, prevalence, hepatolenticular degeneration, penicillamine | Pol Arch Intern Med | 2026 | 0 |
| Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis. PMID 42619594 — stroke, colchicine, secondary prevention, cerebrovascular circulation, cerebrovascular disorders, coronary disease, atherosclerosis, peripheral arterial disease, therapeutics, prognosis | Stroke | 2026 | 0 |
| Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial. PMID 42418305 — hypertension, achievement, blood, stroke, blood pressure, secondary prevention | Eur Stroke J | 2026 | 0 |
| Liver-related autoantibodies in Wilson disease: increased prevalence and unclear clinical significance. PMID 42364731 — autoantibodies, antibodies, liver, prevalence, diagnosis, hepatolenticular degeneration, penicillamine | Adv Med Sci | 2026 | 0 |
Clinical Studies 22
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 2
LeadR Networks
Main global connection map